News

Ten million doses expected by end of Q3

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

Latest report shows that air cargo demand has reached pre-Covid levels

Drone technology delivers doses to difficult-to-reach locations

In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production

Rivals will team up in order to accelerate supply

UK-based OXGENE designs and develops scalable gene therapy technologies

Purchase expands CRO's plans for cell and gene therapy program

Digital therapy tools link drug packaging with matching software—with aim of enhancing participant monitoring

Joins network of manufacturers contributing efforts to increase supply

Linkage to the company’s SensiWatch logistics-tracking technology is built-in

The latest people news happenings over the past month

Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts

Agency allows a stability budget of up to 2 weeks at -25°C

Joins UK consortium to help efficiently manufacture oral solid dosage medication

Deals provide Andlauer Healthcare Group full Skeleton Canada ownership and 49 percent stake in US branch

Country's Ministry of Public Health chooses cannabinoid pharma company as its medical supplier

Supply chain management and logistics company boosts its US presence

Company says it will be able to produce an estimated 12 million doses per month

Pair of agreements expands packaging company's international network

While clock now ticking for life sciences companies to comply with the new data standards, opportunities in the offing to simplify manufacturing and the supply chain

Acquisition is 3PL provider's largest one yet

Acquisition grows Antares’ track-and-trace presence

The importance of thinking strategically about the infrastructure and foresight needed to scale up CGTs—not as treatments of last resort, but first choice

Strengthens the CRO's scientific capabilities in cell and gene therapy space

Lab development project features 9,000-square-foot expansion

Combine their expertise in immunology and infectious diseases to speed up development of mAbs for influenza